HuagongsheHuagongshe Chemie-Druckbericht · Nur für Forschungszwecke
Chlormezanon
Lobak · Rexan · Rilax · Alinam · Bisina · Muskel · win4692 · FENAROL

Identifikatoren & physikalische Daten
| CAS No. | 102818-66-6 |
|---|---|
| Summenformel | C11H12ClNO3S |
| Durchschnittliche Molmasse | 273,74 g/mol |
| Monoisotopische Masse | 273,02264192 g/mol |
| SMILES | CN1C(=O)CCS(=O)(=O)C1c1ccc(Cl)cc1 |
| InChIKey | WEQAYVWKMWHEJO-UHFFFAOYSA-N |
| PubChem CID | 2717 |
| ChEMBL | CHEMBL1200714 |
| ChEBI | CHEBI:3619 |
| EC No. | 201-307-4 |
| DTXSID | DTXSID3022798 |
| Lokaler Name | Chlormezanon |
Chemische & physikalische Eigenschaften
| XLogP | 1,1 |
|---|---|
| Polarare Oberfläche (TPSA) | 62,8 |
| H-Brücken-Donoren | 0 |
| H-Brücken-Akzeptoren | 3 |
| Frei drehbare Bindungen | 1 |
| Schwere Atome | 17 |
| Formalladung | 0 |
| Komplexität | 395 |
| LogP (Verteilungskoeffizient) | 1.3 |
| Color/Form | CRYSTALS |
| Löslichkeit | SOL (% WT/VOL) @ 25 °C: LESS THAN 0.25% IN WATER, LESS THAN 1.0% IN 95% ETHANOLFREELY SOL IN CHLOROFORMSLIGHTLY SOL IN DIETHYL ETHERSPARINGLY SOL IN N-HEXANE1.61e+00 g/LChloroform (Slightly), Ethyl Acetate (Slightly), Methanol (Slightly) |
| Human Drugs | FDA approved drugs -> Active ingredientPharmaceuticals |
| Schmelzpunkt | 116.2-118.6116.2-118.2 °C116.2 °C114 °C |
| Physical Description | Solid |
| Collision Cross Section | 154.1 Ų [M-H]- [CCS Type: DTBuffer gas: N2Ionization: ESI-Dataset: TOXCASTSource Identifier: DTXSID3022798]156.85 Ų [M+H]+ [CCS Type: TWMethod: calibrated with polyalanine and drug standards]158.2 Ų [M+H]+ [CCS Type: TW |
| Siedepunkt | 534.5±50.0 °C(Predicted) |
| Dichte | 1.2205 (rough estimate) |
| Brechungsindex | 1.6300 (estimate) |
| Lagerbedingungen | Sealed in dry,Room Temperature |
| Aggregatzustand | Solid |
| pKa (Säurekonstante) | -2.37±0.40(Predicted) |
| Farbe | White to Pale Yellow |
| Merck | 14,2106 |
| InChI | InChI=1S/C11H12ClNO3S/c1-13-10(14)6-7-17(15,16)11(13)8-2-4-9(12)5-3-8/h2-5,11H,6-7H2,1H3 |
| InChIKey | WEQAYVWKMWHEJO-UHFFFAOYSA-N |
| SMILES | S1(=O)(=O)CCC(=O)N(C)C1C1=CC=C(Cl)C=C1 |
| NIST chemische Informationen | Chlormezanone(80-77-3) |
Sicherheit & Vorschriften
| GHS-Einstufung | WarningH302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]P264, P270, P301+P317, P330, and P501 (click each P-code to see the statement)Aggregated GHS information provided per 4 reports by companies from 2 notifications to the ECHA C&L Inventory. |
|---|---|
| Weitere Sicherheitsinformationen | IMAP assessments - 4H-1,3-Thiazin-4-one, 2-(4-chlorophenyl)tetrahydro-3-methyl-, 1,1-dioxide: Environment tier I assessment |
| Hazard Classes and Categories | Acute Tox. 4 (100%) |
| Wechselwirkungen | CHLORMEZANONE MAY LOWER TOLERANCE OF PATIENTS TO ALCOHOL...POSSIBLE ADDITIVE EFFECTS /WITH CHLORMEZANONE &/ CNS DEPRESSANTS SUCH AS ALCOHOL, PHENOTHIAZINES, BARBITURATES, NARCOTICS, OTHER PSYCHOTHERAPEUTIC AGENTS, & MONOAMINE OXIDASE INHIBITORS. |
| Toxizitätsübersicht | Chlormezanone binds to central benzodiazepine receptors which interact allosterically with GABA receptors. This potentiates the effects of the inhibitory neurotransmitter GABA, increasing the inhibition of the ascending reticular activating system and blocking the cortical and limbic arousal that occurs following stimulation of the reticular pathways. |
| Signs and Symptoms | Symptoms of overdose include drowsiness, weakness, nausea, dizziness, abdominal pain, cerebral oedema and renal tubular necrosis, hyperglycaemia and hypoglycaemia, liver damage, encephalopathy, coma and death. |
| Human Toxicity Excerpts | ...COMMONLY PRODUCE DROWSINESS, DIZZINESS, HEADACHE, BLURRED VISION, WEAKNESS, LETHARGY, ATAXIA, & NYSTAGMUS. NAUSEA, VOMITING, HEARTBURN, & ABDOMINAL DISTRESS...ESP AFTER LARGE ORAL DOES. ...SKIN RASH & PRURITUS &, RARELY, ANAPHYLACTOID REACTIONS & LEUKOPENIA. /CENTRALLY ACTING MUSCLE RELAXANTS/INCIDENCE OF UNTOWARD REACTIONS IS ABOUT 3% & MINOR IN NATURE...MALAISE, EXCITEMENT... PETECHIAE, OR ECCHYMOSES SOMETIMES DEVELOPLIVER DAMAGE...OR ANGIONEUROTIC EDEMA ARE RARE.LETHARGY & FLUSHING HAVE BEEN OBSERVED & JAUNDICE HAS OCCURRED RARELY....ORAL TOXICITY LESS THAN MEPROBAMATE, ZOXAZOLAMINE, OR METHOCARBAMOL. ... IN CLINICAL TRIALS ONLY 2.3% OF 4653 PT HAS SIDE EFFECTS... OVERDOSAGE UP TO 10 G HAS NOT CAUSED DEATH. EVEN LARGE AMT PRODUCE ONLY MILD SIDE EFFECTS. |
Anwendungen & Verwendung
Verwenden
Chlormezanone improves the emotional state of the patient, relieving moderate anxiety and stress. However, it has a number of side effects, and because it does not have any advantage over other anxiolytics, it is rarely used in practice.